CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- 4 Grant or award Director acquired 10 shares (grant or award)
- 4 Grant or award Director acquired 35 shares (grant or award)
- 4 Grant or award Director acquired 29 shares (grant or award)
- 4 Open-market sale Senior Vice President sold 2,000 shares at $558.44 ($1,116,884)
- 4 Open-market sale Executive Vice President sold 10,000 shares at an average $561.91 ($5,619,057)
- 4 Open-market sale Director sold 9,460 shares at an average $562.26 ($5,318,989)
- 4 Open-market sale Senior Vice President sold 2,900 shares at an average $546.24 ($1,584,100)
- 4 Open-market sale Director sold 10,000 shares at an average $549.57 ($5,495,735)
- 4 Open-market sale Director sold 2,500 shares at $539.57 ($1,348,918)
- 4 Open-market sale Senior Vice President sold 3,000 shares at an average $540.00 ($1,620,000)
- 4 Open-market sale Director sold 5,000 shares at an average $537.06 ($2,685,324)
- 4 Gift President & CEO gave 500 shares (gift)
- 4 Open-market sale Director sold 7,632 shares at $528.01 ($4,029,809)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 15 of 74 · 1,467 filings